Ifp Advisors, Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$0.12 - $8.83 $36 - $2,649	-300 Reduced 75.0%	100 $0
Q4 2022 Feb 07, 2023	BUY	$0.11 - $5.46 $11 - $546	100 Added 33.33%	400 $3,000
Q2 2022 Sep 06, 2022	BUY	$0.21 - $0.53 $63 - $159	300 New	300 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.21 - $0.53 $63 - $159	-300 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.32 - $0.67 $64 - $134	200 Added 200.0%	300 $0
Q3 2021 Oct 06, 2021	BUY	$1.01 - $1.82 $101 - $182	100 New	100 $1,000
Q2 2021 Jul 13, 2021	BUY	$1.39 - $2.21 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.27 - $3.42 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$0.94 - $1.89 $2,230 - $4,484	-2,373 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$1.5 - $9.38 $9,594 - $59,994	-6,396 Reduced 72.94%	2,373 $4,000
Q2 2020 Aug 05, 2020	BUY	$4.79 - $8.39 $3,736 - $6,544	780 Added 9.76%	8,769 $69,000
Q4 2019 Jan 17, 2020	SELL	$4.29 - $5.64 $6,435 - $8,460	-1,500 Reduced 15.81%	7,989 $44,000
Q3 2019 Nov 07, 2019	BUY	$4.87 - $7.08 $43,386 - $63,075	8,909 Added 1536.03%	9,489 $48,000
Q1 2019 May 15, 2019	SELL	$5.76 - $8.95 $9.26 Million - $14.4 Million	-1,607,989 Reduced 99.96%	580 $4,000
Q4 2018 Jan 23, 2019	BUY	$5.26 - $7.97 $538,218 - $815,514	102,323 Added 6.79%	1,608,569 $9.39 Million
Q3 2018 Oct 25, 2018	BUY	$4.65 - $7.95 $25,300 - $43,255	5,441 Added 0.36%	1,506,246 $0
Q2 2018 Aug 07, 2018	BUY	$5.05 - $6.8 $2.53 Million - $3.4 Million	500,000 Added 49.96%	1,500,805 $0
Q1 2018 Jun 03, 2019	SELL	$5.6 - $9.25 $1.9 Million - $3.14 Million	-339,750 Reduced 25.34%	1,000,805 $7.11 Million
Q1 2018 May 09, 2018	BUY	$5.6 - $9.25 $1.9 Million - $3.14 Million	339,750 Added 33.95%	1,340,555 $0
Q4 2017 Jan 24, 2018	SELL	$6.6 - $7.78 $1,452 - $1,711	-220 Reduced 0.02%	1,000,805 $0
Q1 2017 Jun 03, 2019	BUY	N/A	475,525 Added 90.49%	1,001,025 $8.26 Million
Q4 2016 Jun 03, 2019	BUY	N/A	524,920 Added 90503.45%	525,500 $4.44 Million
Q1 2016 Jun 03, 2019	BUY	N/A	580	580 $4,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$576,270
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$45,315
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$39,535
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.14B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account